SHARE:  
NEW JERSEY ALLIANCE FOR
CLINICAL AND TRANSLATIONAL SCIENCE


NEWS, EVENTS, and DEADLINES
February 22, 2022
Upcoming NJ ACTS and Rutgers Events
Regulatory Knowledge and Support Core Staff Cafés

Do you need help regarding any facet of human subjects protection, FDA requirements or other regulatory issues? Join the Regulatory Knowledge and Support Core Staff at our cafés.

February 24, 2022
2 - 3 pm

March 14, 2022
10 -11 am


NJ ACTS Special Populations Core Seminar Series

Engaging Underserved Communities in Clinical Trials

Presented by:

Shobha Swaminathan, MD
Associate Professor, Division of Infectious Diseases, Clinical Research Site Leader

Christie Lyn Costanza, MPH, BSN, RN
Associate Director, Clinical Research Operations

Jamir Tuten, BA
Community Engagement Coordinator


This seminar provides an overview of the HIV and COVID-19 Clinical Trials conducted at Rutgers New Jersey Medical School Research With A Heart. Content provided includes the importance of strategic community engagement and their learned successes and challenges during the pandemic.

March 8, 2022
1 - 2 pm





Research Resources Workshop Wednesdays (R2W2)
Seminar Series


Rutgers Brain Imaging
Stephen José Hanson, PhD
Director
Rutgers Brain Imaging Center

David Zald, PhD
Director, Center for Advanced Human Brain Imaging Research, Rutgers
March 9, 2022
4 -5 pm


Spring Institute for Comprehensive Systematic Reviews

Examining Quantitative and Qualitative Evidence in Health Care

As the demand for health care continues to grow, so does the need for easily accessible, up-to-date evidence on best practices in health care. Systematic reviews are an important vehicle for addressing this need. Participants in the Spring Institute will gain a thorough understanding of the process and tools needed to undertake this important form of research and will work on developing an actual proposal.


March 14-18, 2022
9 am - 4 pm

Registration Deadline: February 25, 2022



NJ ACTS BERD Core Spring Workshop Series

Causal Mediation Analysis
Jason Roy, PhD
Chair, Department of Biostatistics and Epidemiology
RUBIES Director

March 17, 2022
3 - 4 pm




Episode 6:
Kids and Covid: What We Know

Host:
Mary Marchetta O'Dowd, MPH
Executive Director, Health Systems and Population Health Integration, RBHS

Guest:
Lawrence C. Kleinman, MD, MPH, FAAP
Chief, Division of Population Health, Quality, and Implementation Science (PopQuIS) 
Rutgers Robert Wood Johnson Medical School
Listen on : APPLESPOTIFYGOOGLEANCHORRADIO PUBLIC
NJ ACTS Services: Clinical Trials Office
Clinical Trials Office


Industry and Government sponsors of clinical research want to work with Rutgers, and frequently reach out to us seeking investigators across a variety of therapeutic areas for various opportunities. The RBHS Clinical Trials Office has created an investigator registry in an effort to efficiently match our clinical research investigators with new opportunities that may be of interest to them.

If you are interested in joining our registry, please CLICK HERE to complete a very brief form in order to provide us with a summary of your research interests and any past experience you may have with conducting clinical trials.


Visit NJ ACTS Services for a Full List of Our Consulting and Other Services

NJ ACTS in the News
NJ ACTS Welcomes Newly Appointed BERD Co-Lead
Brandon Stewart, PhD
Assistant Professor, Department of Sociology
Department of Politics, Office of Population Research
Princeton University

Watch on Vimeo as Dr. Stewart introduces the interdisciplinary field known as: Text as Data.
NJ ACTS Congratulates IFH/CHSR Member and NJ-ACTS Fellow Amesika Nyaku on her appointment by the Governor to Edna Mahan Correctional Facility for Women Board of Trustees!
Amesika N. Nyaku, MD, MS
Assistant Professor and Investigator
Rutgers New Jersey Medical School

Governor Phil Murphy today announced the groundbreaking appointments of Dr. Amesika Nyaku, Tia Ryans, Dr. Johanna Foster, Bonnie Kerness, La’Nae Grant, and Kathleen Witcher to the Edna Mahan Correctional Facility for Women Board of Trustees. The Governor also reappointed Dr. Karma Brown Warren. The appointments will act to create a diverse, highly-engaged, and forward-thinking Board of Trustees that is well-equipped to supervise the operations of the state’s only women’s correctional facility. Read the Full Article

NJ ACTS Congratulates Grant Writing Training Participants
Luigi Brunetti and Cody Smith
on their New Grants
DR. LUIGI BRUNETTI
AWARDED R01 GRANT FROM NIH
Dr. Brunetti, Associate Professor of Pharmacy Practice and Pharmaceutics at the Rutgers Ernest Mario School of Pharmacy, received a RO1 award from NIH in January 2022 for his study, Mechanistic evaluation of melatonin as a protectant against antibiotic associated kidney injury.

Part of his success is attributable to participating in the National Research Mentoring Network-CIC Academic Network (NRMN-CAN) Grant Writing Group hosted at Rutgers. Brunetti learned about the NRMN-CAN grant writing group by way of Dr. Lauren Aleksunes, the Workforce Development Core Lead for the NJ Alliance for Clinical and Translational Sciences (NJ ACTS), and she invited him to participate. “Quite honestly, the clarity of my writing needed help. I had clear ideas but when putting pen to paper it was difficult to present them in way that flowed logically. Grant writing is a tedious task and at times, when writing you become blind to potential gaps in your proposal. The NRMN provided a sounding board to obtain prospective feedback and edits greatly enhancing my grants.”
DR. CODY SMITH
LAUNCHES HIS INDEPENDENT CAREER WITH A K99/R00 GRANT
Dr. Cody Smith, a Postdoctoral Associate in the Department of Pharmacology and Toxicology at the Ernest Mario School of Pharmacy, was awarded a K99/R00 Pathway to Independence Award from the National Institutes of Health (NIH) on elucidating mechanisms of pulmonary disease and toxicity. The award provides for two years of mentored training with Drs. Andrew Gow and Debra Laskin, and an additional three years of funding as an independent investigator.

He credits the NRMN with helping him develop strong application, “My experience with NRMN has reenforced my belief that academic research requires collaboration and peer support. I’ve always been a little apprehensive letting people review and critique my writing because it can be difficult to accept criticism, however receiving feedback on my specific aims pages taught me how invaluable it is to hear from others, particularly those outside of my field…The NRMN group was an excellent networking opportunity for me as a trainee…The NRMN grant writing experience felt very collegial and supportive. The diverse opinions and critiques that were given for the specific aims page for my K99/R00 proposal was truly enlightening. You should consider joining because your specific aims and your grant will be better! “
Upcoming CTSA Events

CLIC TL1 Visiting Scientist Grand Rounds


Targeting N-acetyl-L-aspartate synthesis and transport to treat Canavan leukodystrophy

Presented by:

Vanessa Hull, BS, BA, MS, PhD Candidate
University of California, Davis

February 25, 2022
12 - 1 pm

Transform and Advance Human Health at TS22

Translational Science 2022 is ready to welcome our community of trainees, junior faculty, and senior scientists this April. Are you prepared to transform how we approach translational science and clinical research?

Register today to take advantage of our early bird rate and reserve your spot to reconnect in-person with the ACTS community in Chicago. Explore our scientific sessions and presentations offered during this year's meeting and start planning your TS22 experience.

April 20-22, 2022

Early Bird Registration Deadline: February 28, 2022

NCATS Online Course in Preclinical Translational Science

March 28–May 13

Enhance your translational science skills this spring with a seven-week online course, MEDI 501: Principles of Preclinical Translational Science

A CASE STUDY FROM CANCER DRUG DISCOVERY AND DEVELOPMENT

In this course, students will learn key principles of translational science, taught by way of a case study of a highly successful translational research partnership involving NCATS, the National Cancer Institute (NCI), Northwestern University and the University of Kansas. The partnership produced a promising potential drug shown to inhibit metastasis in animal models, which is being examined in a first-in-human clinical trial. 


Registration now open for 2022 CTSA Program
In-Person Spring Group Meetings

This Chicago, IL event is first in-person spring CTSA Program Group Meetings in over two years!
 
Friday, March 25, 2022
Registration Deadline: Friday, March 4, 2022
 
Friday, April 22 & Saturday, April 23, 2022
Registration Deadline: Friday, April 1, 2022
NJ ACTS Publications

‘Why aren’t you on PrEP? You’re a gay man’: reification of HIV ‘risk’ influences perception and behavior of young sexual minority men and medical providers. Hascher K, Jaiswal J, Lorenzo J, LoSchiavo C, Burton W, Cox A, Dunlap K, Grin B, Griffin M, Halkitis PN. Cult Health Sex. 2021 Dec 30:1-15. PMID: 34965849 DOI: 10.1080/13691058.2021.2018501
In Case You Missed IT
Master’s of Science in Clinical Research Management. Academic Clinical Research Track. This track is especially designed for students with no clinical research or pharmaceutical experience who would like to participate in clinical research at an Academic Medical Center (AMC) functioning as a “study coordinator”. Application Deadline March 1, 2022.
Rare Disease Day at NIH 2022. Each year, NCATS and the NIH Clinical Center sponsor Rare Disease Day to raise awareness about rare diseases and the NIH collaborations that address scientific challenges and advance research for new treatments. February 28, 2022, 10am - 6p. Read More and Add to Your Calendar
Build a Successful Collaboration with NJ ACTS Team Science - The Team Science Core offers general and project-specific consultations on building and maintaining successful research teams and collaborations. To set up a consultation, please fill out the intake form. Read more about the Team Science Core.
NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
Components